WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
the phase I portion of the INLIGHT study evaluating its investigational pipeline candidate, WVE-007, in otherwise healthy individuals who are overweight or living with obesity. What Did WVE's Latest Data Show? Data from this study showed that after six months of follow-up, a single 240 mg dose of WVE-007 demonstrated sustained benefits compared to placebo, including a statistically significant 14% reduction in visceral fat and a 5% reduction in total body fat. Lean mass remained stable with a 2% increase, while additional improvements were observed in waist circumference, which decreased by 3%, and overall body weight, which declined by 1%. However, in the 400 mg group, three-month results showed a 5% reduction in visceral fat and a 0.7% decline in total fat versus placebo following a single dose of WVE-007. Lean mass remained largely unchanged, with a negligible 0.2% decrease, suggesting preservation of muscle, though overall fat reduction was relatively modest at this interim
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Slips as Obesity Data Fails to Convince [Yahoo! Finance]Yahoo! Finance
- WAVE Life Sciences (WVE) had its price target lowered by Bank of America Corporation from $38.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- WAVE Life Sciences (WVE) had its price target lowered by Wells Fargo & Company from $27.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
WVE
Earnings
- 2/26/26 - Miss
WVE
Sec Filings
- 3/26/26 - Form 4
- 2/27/26 - Form 4
- 2/26/26 - Form 10-K
- WVE's page on the SEC website